CoverageForm 410-K10-Q8-K13D13G13F

XENE Xenon Pharmaceuticals Inc. - 8-K

Filed Mar 13, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001193125-26-106144
8.019.01

Item 8.01 - Other Events

44 words

Item 8.01

Other Events

On March 13, 2026, Xenon Pharmaceuticals Inc. announced the meeting, record date and certain other information relating to its 2026 annual meeting of shareholders pursuant to a filing submitted to the System for Electronic Document Analysis and Retrieval in Canada.

Item 9.01 - Financial Statements and Exhibits

61 words

Item 9.01

Financial Statements and Exhibits

(d) Exhibits.

Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed to have been furnished to, but not filed with, the Securities and Exchange Commission:

Exhibit Number

Description

99.1

SEDAR+ filing submitted March 13, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).